FDA

The U.S. plans to make it easier for gay and bisexual men to give blood by easing restrictions on groups that typically face higher risks of HIV.

More than 1.6 million people in the U.S. are allergic to sesame, some so severe that they need injections of epinephrine, a drug used to treat life-threatening reactions

The Biogen company wanted to set an “unjustifiably high” initial price of $56,000 a year for the Alzheimer’s drug, investigators said.

The FDA cleared Upside Foods to use animal cell culture technology to take living cells from chickens and produce cultured animal cell food.

Head shaping pillows are not safe for babies and can raise their “risk of suffocation and death,” the FDA said.

The Food and Drug Administration says amoxicillin is in short supply as cases of RSV increase across the country.

The department also listed a shortage for an oral powder. Amoxicillin is available in chewable tablets or capsules.

The parents of a 23-year-old Georgia man who died after using kratom have filed a wrongful death lawsuit against about a dozen people, companies and organizations connected to the manufacturing, marketing and sale of the herbal supplement

Unilever has issued a voluntary recall of dry shampoo products due to potentially elevated levels of benzene, a chemical known to cause cancer.

The FDA could decide to take a drug meant to prevent premature births off the market. Some regulators say its risks are too great for mothers-to-be.

The maker of a drug intended to reduce premature births is making a last-ditch effort to keep its medication on the market, even as health regulators insist that it doesn’t work.

The notice came more than two months after some pharmacies reported difficulties filling Adderall prescriptions.

The U.S. on Wednesday authorized updated COVID-19 boosters for children as young as 5, seeking to expand protection ahead of an expected winter wave.

Starting Monday, hearing aids will be available for purchase in stores and online without a prescription from a doctor. 

A Cambridge company has won approval for a new drug to treat ALS. For many families, it brings a new sense of hope. The new drug from Cambridge-based Amylyx Pharmaceuticals Inc. is called Relyvrio.  “People with ALS are some of the most strong and incredible people,” said Joshua Cohen, co-CEO and cofounder of Amylyx pharmaceuticals. Cohen and Justin Klee...

The announcement comes ahead of the White House Conference on Hunger, Nutrition, and Health — the first of its kind since a similar event during the Nixon administration

The drug could potentially be a gamechanger in the battle against ALS by extending the lives of people with the condition.

A new internal report by the FDA is the first formal account of what exactly led to the crisis.

U.S. health officials are warning against overuse of the lone drug available to treat monkeypox, saying that even a small mutation in the virus could render the pills ineffective.

A closely watched experimental drug for Lou Gehrig’s disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to approve the treatment for those with the fatal illness.